Urinary Tract Calculi III: Medical Management

Non-contrast CT scans and ultrasounds visualize kidney stones and assess their size and location. Urinalysis detects blood and crystals indicating stone formation. Blood tests measure uric acid and calcium levels, revealing hyperuricemia or hypercalcemia as risk factors. Urine pH measurement helps identify specific stone types, such as struvite stones at alkaline pH and uric acid stones at acidic pH.

Alpha-adrenergic blockers like tamsulosin relax ureteral smooth muscle, facilitating stone passage. These medications are prescribed for stones smaller than 5 millimeters that typically pass spontaneously. By reducing ureteral tension, they improve the likelihood of natural stone expulsion and reduce pain associated with stone movement through the urinary tract.

Thiazide diuretics reduce calcium excretion in urine, lowering stone formation risk. Potassium citrate maintains alkaline urine, which decreases calcium oxalate crystallization. Patients should avoid high-dose vitamin C and calcium supplements, as vitamin C increases oxalate levels. Adequate hydration dilutes urine and further reduces stone-forming substance concentration.

Increased fluid intake dilutes urine and reduces uric acid concentration. Potassium citrate alkalinizes urine to help dissolve existing uric acid stones. Allopurinol reduces uric acid production by inhibiting xanthine oxidase. Patients should limit purine-rich foods like red meat and seafood to decrease uric acid levels and prevent recurrent stone formation.

Acetohydroxamic acid inhibits urease, an enzyme produced by urea-splitting bacteria that contributes to struvite stone formation. This medication is prescribed for patients with retained or recurrent struvite stones when surgical intervention is not an option. Medical therapy alone is usually insufficient; antibiotics manage infections if surgery is deferred or following stone removal to prevent recurrence.

Tiopronin or captopril prevents cystine crystallization and reduces stone formation. Potassium citrate maintains alkaline urine, lowering cystine solubility and promoting dissolution. Adequate hydration further dilutes urine. These combined approaches address the underlying metabolic factors in cystinuria, a genetic condition linked to cystine stone formation.

A 24-hour urine collection measures excretion of calcium, phosphorus, magnesium, sodium, oxalate, citrate, cystine, sulfate, potassium, and uric acid. It assesses total urine volume and identifies underlying metabolic factors contributing to stone formation. This test is recommended for patients with recurrent kidney stones to guide personalized prevention strategies and medication selection based on urinary tract calculi pathophysiology and clinical manifestations.